The ACADIA Pharmaceuticals Inc., ACAD has Gain (↑) on Monday, December 02, 2019 the stock price is settled at $45.78 after buying and selling hours while rehearsed a difference of 1.08 percent. The stock has a fifty two-week low of $226.77 percent while its fifty two-weeks high are $-5.15 percent.
The total market cap for the stock is $7.32B while it has a PE ratio of 0. Active investor focuses on important indicators rehearsed a difference in session that includes where the ACADIA Pharmaceuticals Inc..
Each buying and selling session display one-of-a-kind actions and patterns about ACADIA Pharmaceuticals Inc. (ACAD) stock. Presently we watched the different factors that seen on close of last session. Toward the day’s end, it’s only a stock’s exhibition that issues.
ACADIA Pharmaceuticals Inc.’s overall performance:
The performance of the stock during the last 7.00 days was -2.76 percent,
during the last one-month price index is 7.95 percent while over the 3.00 months is 81.24 percent.
Its 6.00 months performance has been 80.59 percent while for the beyond 52.00 weeks is 127.42 percent.
We have additionally seen that the stock is exchanging 8.98 percent away from the 50-day MA and 48.88 percent of the 20-day MA.
How much shares are traded?
The stock traded hands with 1515144 numbers of shares contrast to its normal every day volume of 2.15M shares.
What amount of stock is unpredictable?
Beta factor was seen at 2.81. Beta estimates the hazard of the security. High beta >1 means implies higher dangerous and low beta <1 shows low peril. The stock remained 3.45 percent erratic for the ongoing week and 4.04 percent for the last month.
ACADIA Pharmaceuticals Inc. has a P/S and P/B values of 24.37 and 9.7 respectively. Its P/Cash valued at 10.7. The ACAD has PEG of 0. Technical indicators do not lead us to assume the stock will see more gains anytime soon.
Analyst’s mean target amount for the company is 54.86 while analysts mean suggestion is 2.